期刊文献+

低氧诱导金属硫蛋白对甲状腺乳头状癌上皮间质转化的影响 被引量:1

Hypoxia-induced metallothioneins promote epithelial-mesenchymal transition of human papillary thyroid carcinoma cells
原文传递
导出
摘要 目的研究低氧诱导金属硫蛋白(metallothioneins,MTs)对甲状腺乳头状癌(papillary thyroid carcinoma,PTC)上皮间质转化(epithelial-mesenchymal transition,EMT)的影响。方法以人甲状腺乳头状癌NPA细胞为研究模型,将其分为正常氧组(21%O2)、低氧组(5%O2)和MTs-siRNA干扰低氧组,Western blot、RT-PCR方法检测各组细胞MTs、上皮细胞钙粘蛋白(E-cadherin)和间质细胞波形蛋白(Vimentin)的表达,Transwell/Matrigel方法检测各组细胞侵袭转移细胞数。结果低氧可诱导NPA细胞表达MTs,并伴随有EMT标志性分子E-cadherin表达的下调和Vimentin表达的升高,侵袭细胞数由正常氧组15.6±2.8增加到40.3±5.1,迁移细胞数由25.1±5.6增加到48.7±7.6,均有统计学差异(P<0.01);MTs靶向干扰可有效抑制低氧诱导的MTs蛋白表达,同时E-cadherin表达回升,Vimentin表达下降,侵袭细胞数仅增加到25.7±4.2,迁移细胞数仅增加到35.5±5.4,与低氧组比较均有统计学差异(P<0.05)。结论低氧所诱导表达的MTs对人PTC细胞发生EMT有促进作用,MTs靶向干扰可使EMT受到部分抑制。 Objective To determine the effects of metallothioneins(MTs) induced by hypoxia on epithelial-mesenchymal transition(EMT) in human papillary thyroid carcinoma NPA cells.Methods NPA cells were divided into 3 groups,normoxia(21% O2),hypoxia(5% O2) and hypoxia with MTs-siRNA.The expression levels of MTs,E-cadherin and Vimentin in the 3 groups of NPA cells were analyzed by Western blotting and RT-PCR.The invasion and metastasis potential of these groups were detected by Transwell/Matrigel assay.Results Hypoxia treatment led to inducible expression of MTs,down-regulated of E-cadherin and up-regulated Vimentin at the same time,which were marker molecules of EMT in NPA cells.Meanwhile,invasive cell population of hypoxia group was increased to 40.3±5.1 from 15.6±2.8 of normoxia group(P0.01).Migrating cell population was increased to 48.7±7.6 from 25.1±5.6 of normoxia group(P0.01).However,the inducible expression of MTs was effectively inhibited by transfection of MTs-siRNA vector in NPA cells,followed by increased expression of E-cadherin and decreased expression of Vimentin.Moreover,invasive and migrating cell population of the hypoxia group with MTs-siRNA were only increased to 25.7±4.2 and 35.5±5.4(P0.05).Conclusion The expression of MTs induced by hypoxia can promote EMT in human papillary thyroid carcinoma.siRNA targeting MTs can partially inhibit EMT promoted by hypoxia.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2011年第7期671-674,共4页 Journal of Third Military Medical University
基金 国家自然科学基金(81072183) 重庆医科大学重点科研项目(XBZD201002)~~
关键词 金属硫蛋白 上皮间质转化 低氧 甲状腺乳头状癌 metallothioneins epithelial-mesenchymal transition hypoxia papillary thyroid carcinoma
  • 相关文献

参考文献16

  • 1陈竟文,宋陆军.甲状腺癌的流行病学新特点[J].中国临床医学,2009,16(5):812-813. 被引量:53
  • 2Lee B J, Wang S G, Lee J C, et al. Level Ⅱb lymph node metastasis in neck dissection for papillary thyroid carcinoma[J]. Arch Otolaryngol Head Neck Surg, 2007, 133(10) : 1028 -1030.
  • 3Mazzaferri E L. A vision for the surgical management of papillary thy roid carcinoma: extensive lymph node compartmental dissections and selective use of radioiodine [ J ]. J Clin Endocrinol Metab, 2009, 94 (4) : 1086 - 1088.
  • 4Thomson S, Buck E, Petti F, et al. Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition [ J ]. Cancer Res, 2005, 65 (20) : 9455 - 9462.
  • 5Pedemen M O, laden A, Stohenberg M, et al. The role of metallothionein in oneogenesis and cancer prognosis [ J ]. Prog Histochem Cytoehem, 2009, 44( 1 ) : 29 -64.
  • 6Mididoddi S, MeGuirt J P, Sens M A, et al. Isoform-specifie expression of metallothionein mRNA in the developing and adult human kid- ney[J]. Toxicol Lett, 1996, 85( 1 ) : 17 -27.
  • 7Bai Y, Kakudo K, Nakamura M, et al. Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma and periostin expression[J]. Cancer Left, 2009, 281 (2) : 188 -195.
  • 8Vasko V, Espinosa A V, Scouten W, et al. Gene expressinn and functional evidence of epithelial-to-mesenchymal transition in papillary thy- roid carcinoma invasion[J]. Proc Natl Acad Sci U S A, 2007, 104 ( 8 ) : 2803 - 2808.
  • 9Hardy R G, Vicente-Duenas C, Gonzalez-Herrero 1, et al. Snail family transcription factors are implicated in thyroid carcinogenesis[ J ]. Am J Pathol, 2007, 171(3) : 1037 - 1046.
  • 10赵晓迎,韩方正.金属硫蛋白研究进展[J].徐州医学院学报,2010,30(5):349-350. 被引量:4

二级参考文献16

  • 1Enewold L, Zhu K, Ron E, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteris tics, 1980 2005[J]. Cancer Epidemiol Biomarkers Prev, 2009 , 18(3) :784-791.
  • 2Ghossein R. Problems and eontroversies in the histopathology of thyroid carcinomas of follicular cell origin[J]. Arch Pathol Lab Med, 2009 ,133(5) :683 -691.
  • 3Ilias I, Alevizaki M, Lakka-Papadodima E, et al. Differentiated thyroid cancer in Greece: 1963 -2000. Relation to demographic and environmental factors[J]. Hormones (Athens), 2002 , 1(3):174-178.
  • 4Harach HR, Ceballos GA. Thyroid cancer, thyroiditis and dietary iodine: a review based on the Salta, Argentina model[J]. Endoer Pathol, 2008 , 19(4):2119-220.
  • 5Grodski S, Delbridge I.. An update on papillary microcarcinoma [J]. Curr OpinOncol, 2009 , 21(1):1-4.
  • 6Tan Y,Sinniah R,Bay BH,et al.Metallothionein expression and nuclear size in benign,borderline,and malignant serous ovarian tumours[J].J Pathol 1999,189(1):60-65.
  • 7Mocchegiani E,Giacconi R,Muti E,et al.Zinc,immune plasticity,aging,and successful aging:role of metallothionein[J].Ann N Y Acad Sci,2004,1019:127-134.
  • 8Romero-Isart N,Jensen LT,Zerbe O,et al.Engineering of metallothionein-3 neuroinhibitory activity into the inactive isoform Metallothionein-1[J].J Biol Chem,2002,277(40):37023-37028.
  • 9Raleigh JA,Chou SC,Calkins-Adams DP,et al.A clinical study of hypoxia and metallothionein protein expression in squamous cell carcinomas[J].Clin Cancer Res,2000,6(3):855-862.
  • 10Kondo Y,Woo ES,Michalska AE,et al.Metallothionein null cells have increased sensitivity to anticancer drugs[J].Cancer Res,1995,55(10):2021-2023.

共引文献56

同被引文献17

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部